Article

Are women underrepresented in cerebrovascular disease clinical trials? A systematic review using the FDA database

2020-11-12

Abstract excerpt

<h4>ABSTRACT</h4> <h4>BACKGROUND AND PURPOSE</h4> Clinical trials provide essential evidence in the US Food and Drug Administration (FDA) drug approval process. Women were underrepresented in the enrollment of clinical trials for many medical conditions other than cerebrovascular disease (CVD). We investigated women’s participation in FDA-registered CVD-related interventional clinical trials and assessed whether w...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: aa6d18f0-ad00-59b4-9077-7338a5d85ca8
DOI: 10.1101/2020.11.09.20227207

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Are women underrepresented in cerebrovascular disease clinical trials? A systematic review using the FDA databaseDOI 10.1101/2020.11.09.20227207Read

Sex Differences in Ischemic Heart Disease: Advances, Obstacles, and Next Steps.Semantic proximity Read

Representation of Older Adults and Women in Randomized Trials of Non-Invasive Imaging for Chest PainSemantic proximity Read

Primary and Secondary Effects of Statin on Cerebro-Cardiovascular Disease Using the Nationwide Health Screening DataSemantic proximity Read

Inclusion of Underrepresented Populations in Cardiovascular Genetics and EpidemiologySemantic proximity Read

Cardiorenal Effects of Angiotensin-converting enzyme inhibitors and Angiotensin receptor blockers in people underrepresented in trials: analysis of routinely collected data with validation against a target trialSemantic proximity Read

The Dearth of Representation in FDA Approved Drug TrialsSemantic proximity Read

Impact of Participation Bias on Disease Prevalence Estimation in the<i>All of Us</i>Research Program: A Case Study of Ischemic Heart Disease and StrokeSemantic proximity Read

Sex Representation in U.S. Clinical Trials: A Statistical Benchmarking StudySemantic proximity Read

Adequate Underrepresented Minority Representation in Cancer Trials: Evidence from an NCI-Designated Center in a Minority CountySemantic proximity Read

Racial and Ethnic Reporting and Representation in Phase III Alzheimer’s Disease Clinical Trials in the USSemantic proximity Read

Uterine Fibroids Increase Stroke Risk: a Mendelian Randomization StudySemantic proximity Read

Cardiovascular disease in Latin American women.Semantic proximity Read